In 2023, the share of scientific publications involving international collaboration in drug discovery in Brazil was approximately 26%. From 2024 onwards, this percentage is forecasted to rise steadily. By 2028, it is expected to reach 32.36%, representing an anticipated increase in international collaboration over the forecast period.
- Between 2024 and 2025, the forecast anticipates a 4.26% growth in international collaboration publications.
- From 2025 to 2026, an estimated 4.05% increase is projected.
- The period between 2026 and 2027 is expected to see a 3.89% growth rate.
- Between 2027 and 2028, a further 3.72% increase is forecasted.
The compound annual growth rate (CAGR) for the 2024 to 2028 period is about 4.06%, indicating a strong and consistent trend towards increased international collaboration in Brazil's drug discovery publications.
Looking ahead, trends to watch include technological advancements facilitating remote collaboration, evolving international regulatory environments, and increasing governmental and private sector investment in joint research initiatives. These factors could further influence the pace and extent of collaborative efforts in Brazil's drug discovery research.
